Bioadaptives (BDPT) Short term Debt (2013 - 2026)

Bioadaptives has disclosed Short term Debt across 13 years of filings, most recently posting $1.6 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $1.6 million, up 57.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 57.72% YoY), and the FY2025 annual result was $1.7 million, up 65.09% from the prior year.
• Short term Debt came in at $1.6 million for Q1 2026 at Bioadaptives, down from $1.7 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $1.7 million in Q4 2025 to a low of $686856.0 in Q4 2022.
• The 5-year median for Short term Debt is $967406.0 (2025), against an average of $990360.9.
• Peak annual rise in Short term Debt reached 65.09% in 2025, while the deepest fall reached 23.33% in 2025.
• Bioadaptives' Short term Debt stood at $686856.0 in 2022, then jumped by 42.37% to $977872.0 in 2023, then climbed by 7.71% to $1.1 million in 2024, then surged by 65.09% to $1.7 million in 2025, then decreased by 10.06% to $1.6 million in 2026.
• The last three Short term Debt figures came in at $1.6 million (Q1 2026), $1.7 million (Q4 2025), and $967406.0 (Q3 2025), per Business Quant data.